AMCP 2013 Nexus: Addressing Critical Pharmacy Issues
Specialty pharmacy, health care reform, clinical breakthroughs and research in managed care are among the featured topics at the AMCP 2013 Nexus, a conference taking place at San Antonio’s Henry B. Gonzalez Convention Center on October 15-18.
Specialty pharmacy, health care reform, clinical breakthroughs and research in managed care are among the featured topics at the AMCP 2013 Nexus, a conference taking place at San Antonio’s Henry B. Gonzalez Convention Center on October 15-18.
National Pharmaceutical Council (NPC) Chief Science Officer Dr. Robert Dubois will take part in the pre-conference AMCP Foundation Symposium (separate registration fee required), Transplanting European Health Technology Assessment (HTA) to America? What’s Wrong with Our Version? on Tuesday, October 15 at 11 am CT. Dr. Dubois will discuss whether the success of accountable care organizations and managed care organizations will be dependent on new risk paradigms for specialty drugs. He’ll address questions such as:
- How much do risk contracts depend on growing rapidly our modeling research and our ability to dissect modeling studies?
- How are concepts and examples of conditional and restricted reimbursement being applied in Europe and in the United States?
- How are patients kept whole in risk contracting?
NPC Director of Comparative Effectiveness Research Dr. Jennifer Graff will join a discussion on the future of formulary decision-making data and how it will increasingly derive from comparative effectiveness research (CER) and other newer sources of data (e.g., administrative claims, electronic health records, simulations of health outcomes)on Thursday, October 17 at 9:45 am CT. Recognizing the need for guidance to assess these data as part of the full “body of evidence,” the Academy of Managed Care Pharmacy (AMCP), the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) and the National Pharmaceutical Council collaborated on an online tool for evaluating CER.